Literature DB >> 9889452

Colorectal cancer screening: discussions with first degree relatives.

M A Harris1, C J Treloar, J E Byles.   

Abstract

Screening by faecal occult blood test and colonoscopy is recommended for first degree relatives of people with colorectal cancer. While it is known that screening participation among relatives is low, relatives' beliefs and attitudes towards screening have not been explored at an in-depth level. In this study, four focus group discussions with first degree relatives of people with colorectal cancer were held. Discussions were audio-taped, transcribed verbatim and the data were independently coded and analysed by the authors. Three main themes were identified: risk, understanding, and screening. Perceived risk was determined by family history, age and gender. Of concern, there was limited understanding of the asymptomatic nature of screening with most relatives initially 'screened' after consulting a doctor with colorectal symptoms. These findings need to be considered in screening programs.

Entities:  

Mesh:

Year:  1998        PMID: 9889452     DOI: 10.1111/j.1467-842x.1998.tb01502.x

Source DB:  PubMed          Journal:  Aust N Z J Public Health        ISSN: 1326-0200            Impact factor:   2.939


  9 in total

1.  Do colorectal cancer patients understand that their family is at risk?

Authors:  David T Rubin; Rishi K Gandhi; Jeremy T Hetzel; Sydney H Kinnear; Andrew Aronsohn; Gordon Wood; Nicole Yadron
Journal:  Dig Dis Sci       Date:  2009-11       Impact factor: 3.199

2.  Screening practices of unaffected people at familial risk of colorectal cancer.

Authors:  Driss Ait Ouakrim; Alex Boussioutas; Trevor Lockett; Ingrid Winship; Graham G Giles; Louisa B Flander; Louise Keogh; John L Hopper; Mark A Jenkins
Journal:  Cancer Prev Res (Phila)       Date:  2011-10-26

3.  Perceived versus predicted risks of colorectal cancer and self-reported colonoscopies by members of mismatch repair gene mutation-carrying families who have declined genetic testing.

Authors:  Louisa Flander; Andrew Speirs-Bridge; Alison Rutstein; Heather Niven; Aung Ko Win; Driss Ait Ouakrim; John L Hopper; Finlay Macrae; Louise Keogh; Clara Gaff; Mark Jenkins
Journal:  J Genet Couns       Date:  2013-06-09       Impact factor: 2.537

Review 4.  Lay understanding of familial risk of common chronic diseases: a systematic review and synthesis of qualitative research.

Authors:  Fiona M Walter; Jon Emery; Dejana Braithwaite; Theresa M Marteau
Journal:  Ann Fam Med       Date:  2004 Nov-Dec       Impact factor: 5.166

5.  An examination of the psychosocial factors influencing colorectal cancer patients' communication of colorectal cancer patient risk with their siblings.

Authors:  Catalina Lawsin; Katherine Duhamel; Steven Itzkowitz; Karen Brown; Helen Lim; Lina Jandorf
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-11       Impact factor: 4.254

6.  Interactions among physicians, patients, and first-degree relatives in the familial screening of colorectal cancer in France.

Authors:  Isabelle Ingrand; Sarah Dujoncquoy; Virginie Migeot; Véronique Ghadi; Michel Beauchant; Pierre Ingrand
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

7.  A qualitative evaluation of the psychosocial impact of family history screening in Australian primary care.

Authors:  Gabrielle T Reid; Fiona M Walter; Jon D Emery
Journal:  J Genet Couns       Date:  2014-10-03       Impact factor: 2.537

8.  Determinants of participation in colonoscopic screening by siblings of colorectal cancer patients in France.

Authors:  Myriam Taouqi; Isabelle Ingrand; Michel Beauchant; Virginie Migeot; Pierre Ingrand
Journal:  BMC Cancer       Date:  2010-07-06       Impact factor: 4.430

9.  Psychological Barriers and Facilitators of Colorectal Cancer Screening: A French Qualitative Study.

Authors:  Morgiane Bridou; Colette Aguerre; Guillaume Gimenes; Violaine Kubiszewski; Armel Le Gall; Catherine Potard; Olivier Sorel; Christian Reveillere
Journal:  Health Psychol Res       Date:  2013-06-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.